Horizons Psychedelic Stock ETF (DELISTED) (PSYK.NO:DL)
6.55
0.00 (0.00%)
CAD |
NEO |
Apr 01, 16:00
Price Chart
Key Stats
| Net Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 1.00% | -- | 9.130M | 9511.63 |
| Dividend Yield | Turnover Ratio | 1 Year Fund Level Flows | Max Drawdown (Since Inception) |
| -- | 71.82% | -3.682M | Upgrade |
Basic Info
| Investment Strategy | |
| PSYK seeks to replicate, to the extent possible and net of expenses, the performance of a market index that is designed to provide exposure to the performance of a basket of North American publicly-listed life sciences companies having significant business activities in, or significant exposure to, the psychedelics industry. Currently, PSYK seeks to replicate the performance of the North American Psychedelics Index, net of expenses. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Small Cap/Value |
| Fixed Income Style | -- |
| Broad Asset Class | -- |
| Broad Category | Equity |
| Category Name | Sector Equity |
| Category Index | Morningstar Gbl GR CAD |
| Global Category Name | Equity Miscellaneous |
| YCharts Categorization | Other |
| YCharts Benchmark | S&P 500 Total Return (^SPXTR) |
| Prospectus Objective | -- |
| Fund Owner Firm Name | Horizons ETFs Management (Canada) Inc |
| Prospectus Benchmark Index | |
| North American Psychedelics TR CAD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPTSX60TR | 100.0% |
| Manager Tenure | |
| Not Disclosed | 3.10 yrs |
Performance Versus Category
Annual Total Returns Versus Peers
As of April 01, 2024.
Basic Info
| Investment Strategy | |
| PSYK seeks to replicate, to the extent possible and net of expenses, the performance of a market index that is designed to provide exposure to the performance of a basket of North American publicly-listed life sciences companies having significant business activities in, or significant exposure to, the psychedelics industry. Currently, PSYK seeks to replicate the performance of the North American Psychedelics Index, net of expenses. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Small Cap/Value |
| Fixed Income Style | -- |
| Broad Asset Class | -- |
| Broad Category | Equity |
| Category Name | Sector Equity |
| Category Index | Morningstar Gbl GR CAD |
| Global Category Name | Equity Miscellaneous |
| YCharts Categorization | Other |
| YCharts Benchmark | S&P 500 Total Return (^SPXTR) |
| Prospectus Objective | -- |
| Fund Owner Firm Name | Horizons ETFs Management (Canada) Inc |
| Prospectus Benchmark Index | |
| North American Psychedelics TR CAD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPTSX60TR | 100.0% |
| Manager Tenure | |
| Not Disclosed | 3.10 yrs |